Human papilloma virus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology.
The purpose of this study was to demonstrate the prevalence of cervical human papilloma virus (HPV) infection correlated to reason for attending an STD clinic, presence of clinical signs of HPV infection, concomitant infection and abnormal cytology. Samples from the cervical canals of 588 consecutive women attending the STD clinic, Department of Dermato-Venereology, Sahlgrenska Hospital, Gothenburg, were taken with a Cytobrush for detection of HPV DNA with the dot blot/Southern-blot technique. Visible condylomata, i.e. filiform or papular condylomata, were registered. Acetic acid test and colposcopy were not routinely performed. Cytological examination was performed as well as isolation of Chlamydia trachomatis on Mc Coy's cells and culture on Sabouraud agar for Candida albicans. The prevalence of HPV DNA was 8% (48/588). In the group of 233 women attending because of concern about HPV infection, 94 (40%) had visible signs of HPV infection and 30 (13%) were positive for HPV DNA in the cervix. In 355 women attending for other reasons, such as discharge, pruritus or STD check-up, 4 (1%) had visible signs of HPV infection and 18 (5%) were HPV DNA positive. Of 98 women with visible signs of vulvar/vaginal HPV infection, 33 (34%) were HPV-positive in the cervix with a commercial Southern-blot test. Of 490 patients without visible signs of HPV infection, 15 (3%) were HPV-positive in the cervix. In the group of HPV-positive women a positive culture for Candida was demonstrated in 26% (11/43), Compared to 16% (79/504) of the HPV-negative women.(ABSTRACT TRUNCATED AT 250 WORDS)
Voog
E
E
Department of Dermato-Venerology, Sahlgrenska Hospital, Gothenburg, Sweden.
Bolmstedt
A
A
Olofsson
S
S
Ryd
W
W
Löwhagen
G B
GB
D000293:Adolescent; D000328:Adult; D000368:Aged; D002181:Candidiasis, Vulvovaginal / Q000453:epidemiology / Q000473:pathology; D002690:Chlamydia Infections / Q000453:epidemiology / Q000473:pathology; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D015897:Comorbidity; D003218:Condylomata Acuminata / Q000453:epidemiology / Q000473:pathology / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000473:pathology; D012749:Sexually Transmitted Diseases / Q000453:epidemiology* / Q000473:pathology; D013548:Sweden / Q000453:epidemiology; D014412:Tumor Virus Infections / Q000453:epidemiology* / Q000473:pathology; D002577:Uterine Cervical Diseases / Q000453:epidemiology* / Q000473:pathology / Q000821:virology*; D014623:Vaginal Diseases / Q000453:epidemiology / Q000473:pathology / Q000821:virology; D014626:Vaginal Smears; D014845:Vulvar Diseases / Q000453:epidemiology / Q000473:pathology / Q000821:virology
D004279:DNA, Viral